DNUT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Krispy Kreme Inc (DNUT) is not a compelling buy for a beginner investor with a long-term focus at this time. The technical indicators are neutral to bearish, options data does not show strong bullish sentiment, and the company's financial performance is weak with declining revenue and negative net income. While there are some positive catalysts such as hedge fund buying and new product launches, these are not sufficient to offset the overall weak fundamentals and lack of strong upward momentum.
The technical indicators for DNUT are neutral to bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 48.663, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock price is near its pivot level of 3.373, with resistance at 3.504 and support at 3.242.
Hedge funds have increased their buying activity by 115.53% over the last quarter.
Krispy Kreme is launching new products and leveraging popular culture with the 'Malcolm in the Middle Mix Pack' and Spring Seasonal Collection, which could drive short-term consumer interest.
Weak financial performance with declining revenue (-2.88% YoY) and negative net income, despite some improvement in margins.
Analysts' ratings and price targets are mixed, with no strong consensus for significant upside.
Lack of recent congress trading data or significant insider buying activity.
In Q4 2025, Krispy Kreme reported a revenue decline of -2.88% YoY to $392.37M. Net income improved but remained negative at -$32.08M (+42.94% YoY). EPS increased to -0.19 (+46.15% YoY), and gross margin improved slightly to 18.33%. Overall, the financials indicate weak growth trends and ongoing profitability challenges.
Analysts' ratings are mixed. Capital One recently upgraded the stock to Overweight with a $6 price target, but other firms like Citi and Evercore ISI maintain Neutral or In Line ratings with modest price targets ($4-$4.50). BofA has a Buy rating but lowered its target to $5, while Morgan Stanley remains bearish with an Underweight rating and a $3 target.
